Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Pfizer PFE Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-149,877	Closed	-$4.85M	–	86
2023 Q3	$4.85M	Sell	149,877 -62,325	-29%	-$2.2M	0.36%	70
2023 Q2	$7.69M	Buy	+212,202	New	+$8.26M	0.55%	59

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's PFE Position: Q4 2023 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of Pfizer (PFE) in Q4 2023, closing a stake of 149,877 shares — an estimated $4.85M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in PFE in Q2 2023 and held it in 2 quarters. The position peaked at $7.69M in Q2 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 149,877 Pfizer shares in Q4 2023, an estimated $4.85M.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in Pfizer in Q2 2023 and held it in 2 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's Pfizer position peaked at $7.69M in Q2 2023.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q4 2023, filed 24 Jan 2024.